...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: July 15, 2016
Reply New Message
Back To Forum List View
July 15, 2016
1
Stock2740
Jul 06, 2016 04:15PM

I'm pretty sure Don mentioned July 31 as the official reorganization date in the webcast.

In other news, today marks 3 weeks from the first dosing of ZEN-3694. So based on the trial design, they should be increasing to the next dose level any day now, barring any setbacks.

BearDownAZ

4 Recommendations
Icon president Dosing schedule for ZEN-3694
6
BearDownAZ
Jul 13, 2016 05:10PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply